je.st
news
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now ...
2015-10-10 05:30:50| Biotech - Topix.net
In the world of biopharma, it doesn't take long for a company to copy or mimic a popular, successful drug. In fact, for some less-common diseases, the industry realizes that merely sharing the revenue generated by a small niche may not even be worth the effort, meaning those rare or difficult-to-treat diseases often go completely unaddressed.
Tags: now
status
drug
armed
Category:Biotechnology and Pharmaceuticals